Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

3588.64

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£3,588.64

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

20 November 2012

Number of Pages

138

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

BCC Research

File Format

PDF

Global MicroRNA research tools market to reach value of $736 million by 2017

During 2011 the microRNA research tools market reached a global value $295.3 million. This year (2012), the market is expected to have continued on its growth trajectory with a value expected to total $338.3 million. Over the longer the term the market is suggested the keep up the momentum, and reach a high of $736 million by 2017. Worked out as a CAGR percentage, the microRNA research tools market will have grown at a CAGR of 17.7% between 2012 and 2017.

The microRNA research tools market can be broken down into a number of specific sectors. The largest of these sectors is the tools and reagents sector, which will hit a value of $640 million by 2017, after reaching $278 million during 2012. The therapeutics sector of microRNA will reach $120 million by 2017, after gaining a value of $60 million in 2012.

RNA represents one of the three major macromolecules (along with DNA and proteins) essential for cell function. Similar to DNA, RNA consists of a long chain of nucleotides when the sequence of these molecules encodes genetic information. The main difference between the DNA and RNA sequence is the nucleobase uracil in the RNA sequence, while DNA contains thymine (a methylated form of uracil). In addition, unlike DNA, most RNA molecules are single-stranded. Consequently, single-stranded RNA can adopt very complex, three-dimensional structures essential for the proper function and regulation of cellular processes.

Reasons for Doing this Study

The microRNA phenomenon was discovered in the early 1990s. Yet only now scientists and industry insiders are recognizing the importance of this discovery.

The microRNA biogenesis process is essentially the basis for current RNA interference drug discovery and therapeutics research. It led to the development of a very important experimental approach of gene silencing by synthetic double stranded RNA molecules. Today, siRNA tools are among the routine laboratory techniques and essential requirements for scientific proof of concept. Moreover, scientists came to realize that the microRNA silencing pathway is efficient in downregulation of number of target genes, which makes it better in terms of therapeutics development. More importantly, the microRNA expression profile represents critical signatures for biomarker and diagnostic product development.

These facts force diagnostics and therapeutics companies to reconsider microRNA space and to look more closely into microRNA research, diagnostics and therapeutics product development.

Although microRNAs are part of the RNA research market in general, the microRNA sector exhibits specific characteristics and differences in its market participants and competitive landscape.

This report highlights the main segments in the microRNA market: reagents and tools essential for research, current diagnostics products and their development, and drug candidates in the pipelines of different companies. This report also discusses major players, current and future trends, and influences. Drivers and challenges in each segment of this industry are described in detail, including forecasts for the next five years.

Study Goals and Objectives

This report, MicroRNA Diagnostics and Therapeutics: Technologies and Global Markets, provides an overview of the current state of the microRNA market, focusing specifically on tools, reagents, techniques, diagnostics and therapeutics products. It describes products and tests currently on the market and a detailed analysis of the competitive environments, including new potential trends and markets for novel products and assay development. This study includes information about significant players, trends, and obstacles and other information affecting this market and its different sectors.

Scope and Format

This report is a business tool that can help market players properly evaluate new commercial opportunities in the microRNA reagent, diagnostic and therapeutic submarkets. The geographic scope of this study is global. This market is generally complex and consists of a number of different segments, each of which is affected differently by scientific and technological developments. This report identifies the main factors affecting each segment, and forecasts market growth, future trends, and product development in every major segment of this market.

Methodology and Information Sources

Both primary and secondary research methodologies were used in preparing this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis were also conducted.

In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotechnology and pharmaceutical companies. Other sources included academics, technology, and consulting companies. Subsequent analysis of the documents and interview notes was iterative.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£3,588.64

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Healthcare and Medical Company Profiles

Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Accessibility
Close

Contrast settings

Text size settings